Genetic Testing for Safe Medication Market - Global Outlook and Forecast 2021-2027

April 2021 | 90 pages | ID: G0C02AE35B3FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Genetic Testing for Safe Medication in Global, including the following market information:

Global Genetic Testing for Safe Medication Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Genetic Testing for Safe Medication market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genetic Testing for Safe Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Genetic Testing for Safe Medication Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Genetic Testing for Safe Medication Market Segment Percentages, By Type, 2020 (%)

• Oral Mucosa Collection
• FTA Blood Sample Collection

China Genetic Testing for Safe Medication Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Genetic Testing for Safe Medication Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic

Global Genetic Testing for Safe Medication Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Genetic Testing for Safe Medication Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Genetic Testing for Safe Medication Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Genetic Testing for Safe Medication Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Premed
• Inmedi
• Yin Feng Gene
• United Gene Group
• KingMed
• Geneis
• Sansure

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Genetic Testing for Safe Medication Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Genetic Testing for Safe Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENETIC TESTING FOR SAFE MEDICATION OVERALL MARKET SIZE

2.1 Global Genetic Testing for Safe Medication Market Size: 2021 VS 2027
2.2 Global Genetic Testing for Safe Medication Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Genetic Testing for Safe Medication Players in Global Market
3.2 Top Global Genetic Testing for Safe Medication Companies Ranked by Revenue
3.3 Global Genetic Testing for Safe Medication Revenue by Companies
3.4 Top 3 and Top 5 Genetic Testing for Safe Medication Companies in Global Market, by Revenue in 2020
3.5 Global Companies Genetic Testing for Safe Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genetic Testing for Safe Medication Players in Global Market
  3.6.1 List of Global Tier 1 Genetic Testing for Safe Medication Companies
  3.6.2 List of Global Tier 2 and Tier 3 Genetic Testing for Safe Medication Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Genetic Testing for Safe Medication Market Size Markets, 2021 & 2027
  4.1.2 Oral Mucosa Collection
  4.1.3 FTA Blood Sample Collection
4.2 By Type - Global Genetic Testing for Safe Medication Revenue & Forecasts
  4.2.1 By Type - Global Genetic Testing for Safe Medication Revenue, 2016-2021
  4.2.2 By Type - Global Genetic Testing for Safe Medication Revenue, 2022-2027
  4.2.3 By Type - Global Genetic Testing for Safe Medication Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Genetic Testing for Safe Medication Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
5.2 By Application - Global Genetic Testing for Safe Medication Revenue & Forecasts
  5.2.1 By Application - Global Genetic Testing for Safe Medication Revenue, 2016-2021
  5.2.2 By Application - Global Genetic Testing for Safe Medication Revenue, 2022-2027
  5.2.3 By Application - Global Genetic Testing for Safe Medication Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Genetic Testing for Safe Medication Market Size, 2021 & 2027
6.2 By Region - Global Genetic Testing for Safe Medication Revenue & Forecasts
  6.2.1 By Region - Global Genetic Testing for Safe Medication Revenue, 2016-2021
  6.2.2 By Region - Global Genetic Testing for Safe Medication Revenue, 2022-2027
  6.2.3 By Region - Global Genetic Testing for Safe Medication Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Genetic Testing for Safe Medication Revenue, 2016-2027
  6.3.2 US Genetic Testing for Safe Medication Market Size, 2016-2027
  6.3.3 Canada Genetic Testing for Safe Medication Market Size, 2016-2027
  6.3.4 Mexico Genetic Testing for Safe Medication Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Genetic Testing for Safe Medication Revenue, 2016-2027
  6.4.2 Germany Genetic Testing for Safe Medication Market Size, 2016-2027
  6.4.3 France Genetic Testing for Safe Medication Market Size, 2016-2027
  6.4.4 U.K. Genetic Testing for Safe Medication Market Size, 2016-2027
  6.4.5 Italy Genetic Testing for Safe Medication Market Size, 2016-2027
  6.4.6 Russia Genetic Testing for Safe Medication Market Size, 2016-2027
  6.4.7 Nordic Countries Genetic Testing for Safe Medication Market Size, 2016-2027
  6.4.8 Benelux Genetic Testing for Safe Medication Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Genetic Testing for Safe Medication Revenue, 2016-2027
  6.5.2 China Genetic Testing for Safe Medication Market Size, 2016-2027
  6.5.3 Japan Genetic Testing for Safe Medication Market Size, 2016-2027
  6.5.4 South Korea Genetic Testing for Safe Medication Market Size, 2016-2027
  6.5.5 Southeast Asia Genetic Testing for Safe Medication Market Size, 2016-2027
  6.5.6 India Genetic Testing for Safe Medication Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Genetic Testing for Safe Medication Revenue, 2016-2027
  6.6.2 Brazil Genetic Testing for Safe Medication Market Size, 2016-2027
  6.6.3 Argentina Genetic Testing for Safe Medication Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Genetic Testing for Safe Medication Revenue, 2016-2027
  6.7.2 Turkey Genetic Testing for Safe Medication Market Size, 2016-2027
  6.7.3 Israel Genetic Testing for Safe Medication Market Size, 2016-2027
  6.7.4 Saudi Arabia Genetic Testing for Safe Medication Market Size, 2016-2027
  6.7.5 UAE Genetic Testing for Safe Medication Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Premed
  7.1.1 Premed Corporate Summary
  7.1.2 Premed Business Overview
  7.1.3 Premed Genetic Testing for Safe Medication Major Product Offerings
  7.1.4 Premed Genetic Testing for Safe Medication Revenue in Global (2016-2021)
  7.1.5 Premed Key News
7.2 Inmedi
  7.2.1 Inmedi Corporate Summary
  7.2.2 Inmedi Business Overview
  7.2.3 Inmedi Genetic Testing for Safe Medication Major Product Offerings
  7.2.4 Inmedi Genetic Testing for Safe Medication Revenue in Global (2016-2021)
  7.2.5 Inmedi Key News
7.3 Yin Feng Gene
  7.3.1 Yin Feng Gene Corporate Summary
  7.3.2 Yin Feng Gene Business Overview
  7.3.3 Yin Feng Gene Genetic Testing for Safe Medication Major Product Offerings
  7.3.4 Yin Feng Gene Genetic Testing for Safe Medication Revenue in Global (2016-2021)
  7.3.5 Yin Feng Gene Key News
7.4 United Gene Group
  7.4.1 United Gene Group Corporate Summary
  7.4.2 United Gene Group Business Overview
  7.4.3 United Gene Group Genetic Testing for Safe Medication Major Product Offerings
  7.4.4 United Gene Group Genetic Testing for Safe Medication Revenue in Global (2016-2021)
  7.4.5 United Gene Group Key News
7.5 KingMed
  7.5.1 KingMed Corporate Summary
  7.5.2 KingMed Business Overview
  7.5.3 KingMed Genetic Testing for Safe Medication Major Product Offerings
  7.5.4 KingMed Genetic Testing for Safe Medication Revenue in Global (2016-2021)
  7.5.5 KingMed Key News
7.6 Geneis
  7.6.1 Geneis Corporate Summary
  7.6.2 Geneis Business Overview
  7.6.3 Geneis Genetic Testing for Safe Medication Major Product Offerings
  7.6.4 Geneis Genetic Testing for Safe Medication Revenue in Global (2016-2021)
  7.6.5 Geneis Key News
7.7 Sansure
  7.7.1 Sansure Corporate Summary
  7.7.2 Sansure Business Overview
  7.7.3 Sansure Genetic Testing for Safe Medication Major Product Offerings
  7.4.4 Sansure Genetic Testing for Safe Medication Revenue in Global (2016-2021)
  7.7.5 Sansure Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Genetic Testing for Safe Medication Market Opportunities & Trends in Global Market
Table 2. Genetic Testing for Safe Medication Market Drivers in Global Market
Table 3. Genetic Testing for Safe Medication Market Restraints in Global Market
Table 4. Key Players of Genetic Testing for Safe Medication in Global Market
Table 5. Top Genetic Testing for Safe Medication Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Genetic Testing for Safe Medication Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Genetic Testing for Safe Medication Revenue Share by Companies, 2016-2021
Table 8. Global Companies Genetic Testing for Safe Medication Product Type
Table 9. List of Global Tier 1 Genetic Testing for Safe Medication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genetic Testing for Safe Medication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Genetic Testing for Safe Medication Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Genetic Testing for Safe Medication Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Genetic Testing for Safe Medication Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Genetic Testing for Safe Medication Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Genetic Testing for Safe Medication Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Genetic Testing for Safe Medication Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Genetic Testing for Safe Medication Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Genetic Testing for Safe Medication Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Genetic Testing for Safe Medication Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Genetic Testing for Safe Medication Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Genetic Testing for Safe Medication Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Genetic Testing for Safe Medication Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Genetic Testing for Safe Medication Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Genetic Testing for Safe Medication Revenue, (US$, Mn), 2022-2027
Table 30. Premed Corporate Summary
Table 31. Premed Genetic Testing for Safe Medication Product Offerings
Table 32. Premed Genetic Testing for Safe Medication Revenue (US$, Mn), (2016-2021)
Table 33. Inmedi Corporate Summary
Table 34. Inmedi Genetic Testing for Safe Medication Product Offerings
Table 35. Inmedi Genetic Testing for Safe Medication Revenue (US$, Mn), (2016-2021)
Table 36. Yin Feng Gene Corporate Summary
Table 37. Yin Feng Gene Genetic Testing for Safe Medication Product Offerings
Table 38. Yin Feng Gene Genetic Testing for Safe Medication Revenue (US$, Mn), (2016-2021)
Table 39. United Gene Group Corporate Summary
Table 40. United Gene Group Genetic Testing for Safe Medication Product Offerings
Table 41. United Gene Group Genetic Testing for Safe Medication Revenue (US$, Mn), (2016-2021)
Table 42. KingMed Corporate Summary
Table 43. KingMed Genetic Testing for Safe Medication Product Offerings
Table 44. KingMed Genetic Testing for Safe Medication Revenue (US$, Mn), (2016-2021)
Table 45. Geneis Corporate Summary
Table 46. Geneis Genetic Testing for Safe Medication Product Offerings
Table 47. Geneis Genetic Testing for Safe Medication Revenue (US$, Mn), (2016-2021)
Table 48. Sansure Corporate Summary
Table 49. Sansure Genetic Testing for Safe Medication Product Offerings
Table 50. Sansure Genetic Testing for Safe Medication Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Genetic Testing for Safe Medication Segment by Type
Figure 2. Genetic Testing for Safe Medication Segment by Application
Figure 3. Global Genetic Testing for Safe Medication Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Genetic Testing for Safe Medication Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Genetic Testing for Safe Medication Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genetic Testing for Safe Medication Revenue in 2020
Figure 8. By Type - Global Genetic Testing for Safe Medication Revenue Market Share, 2016-2027
Figure 9. By Application - Global Genetic Testing for Safe Medication Revenue Market Share, 2016-2027
Figure 10. By Region - Global Genetic Testing for Safe Medication Revenue Market Share, 2016-2027
Figure 11. By Country - North America Genetic Testing for Safe Medication Revenue Market Share, 2016-2027
Figure 12. US Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Genetic Testing for Safe Medication Revenue Market Share, 2016-2027
Figure 16. Germany Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 17. France Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Genetic Testing for Safe Medication Revenue Market Share, 2016-2027
Figure 24. China Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 28. India Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Genetic Testing for Safe Medication Revenue Market Share, 2016-2027
Figure 30. Brazil Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Genetic Testing for Safe Medication Revenue Market Share, 2016-2027
Figure 33. Turkey Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Genetic Testing for Safe Medication Revenue, (US$, Mn), 2016-2027
Figure 37. Premed Genetic Testing for Safe Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Inmedi Genetic Testing for Safe Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Yin Feng Gene Genetic Testing for Safe Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. United Gene Group Genetic Testing for Safe Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. KingMed Genetic Testing for Safe Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Geneis Genetic Testing for Safe Medication Revenue Year Over Year Growth (US$, Mn) & (2016-2021)